CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 22,011	$ 29,922
Grant receivables	3,369	1,281
Prepaid expenses and other current assets	1,450	3,019
Total current assets	26,830	34,222
Property and equipment, net	207	284
Right-of-use assets, operating leases	542	657
Total assets	27,579	35,163
Current liabilities:
Accounts payable	1,895	3,695
Accrued expenses	9,505	4,055
Deferred grant income, current	1,117	1,701
Operating lease liabilities, current	188	174
Other current liabilities		544
Total current liabilities	12,705	10,169
Operating lease liabilities, non-current	392	520
Total liabilities	13,097	10,689
Commitments and contingencies (Note 6)
Stockholders' equity:
Preferred stock, $0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding at September 30, 2024 and December 31, 2023
Common stock, $0.001 par value, 250,000,000 shares authorized; 40,806,092 and 32,165,478 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively	41	32
Additional paid-in capital	181,759	165,826
Accumulated deficit	(167,318)	(141,189)
Accumulated other comprehensive loss		(195)
Total stockholders' equity	14,482	24,474
Total liabilities and stockholders' equity	$ 27,579	$ 35,163

The amount of current portion of deferred grant income as at the end of the reporting period.

No definition available.

Name:	cgtx_DeferredGrantIncomeCurrent
Namespace Prefix:	cgtx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).